340-LB: Optogenetic Control of a-Cell Electrical Activity and Glucagon Secretion in Intact Islets

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 340-LB
Author(s):  
CAROLINE A. MIRANDA ◽  
HAIQIANG DOU ◽  
JOHAN TOLö ◽  
ANDREI I. TARASOV ◽  
PATRIK RORSMAN
Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 339-LB
Author(s):  
HAIQIANG DOU ◽  
CAROLINE A. MIRANDA ◽  
QUAN ZHANG ◽  
PATRIK RORSMAN ◽  
JOHAN TOLö

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2174-P
Author(s):  
MOLLY K. ALTMAN ◽  
PRASANNA DADI ◽  
DAVID JACOBSON
Keyword(s):  

2003 ◽  
Vol 773 ◽  
Author(s):  
Shalini Prasad ◽  
Mo Yang ◽  
Xuan Zhang ◽  
Yingchun Ni ◽  
Vladimir Parpura ◽  
...  

AbstractCharacterization of electrical activity of individual neurons is the fundamental step in understanding the functioning of the nervous system. Single cell electrical activity at various stages of cell development is essential to accurately determine in in-vivo conditions the position of a cell based on the procured electrical activity. Understanding memory formation and development translates to changes in the electrical activity of individual neurons. Hence, there is an enormous need to develop novel ways for isolating and positioning individual neurons over single recording sites. To this end, we used a 3x3 multiple microelectrode array system to spatially arrange neurons by applying a gradient AC field. We characterized the electric field distribution inside our test platform by using two dimensiona l finite element modeling (FEM) and determined the location of neurons over the electrode array. Dielectrophoretic AC fields were utilized to separate the neurons from the glial cells and to position the neurons over the electrodes. The neurons were obtained from 0-2-day-old rat (Sprague-Dawley) pups. The technique of using electric fields to achieve single neuron patterning has implications in neural engineering, elucidating a new and simpler method to develop and study neuronal activity as compared to conventional microelectrode array techniques.


1972 ◽  
Vol 50 (6) ◽  
pp. 523-532 ◽  
Author(s):  
O. F. Schanne

Beating cell clusters were obtained by trypsinization from hearts of newborn rats. Spontaneous activity ceased after several weeks while the cultures were still proliferating. Experiments were performed to identify the physiological determinant causing cessation of spontaneous activity. (a) Cell clusters having lost their spontaneous activity responded to extracellular stimulation. (b) Reduction of [K]o by 50% increased the number of beating cell clusters by 40%; doubling [K]o reduced the number of beating cell clusters by 49%. (c) Cell clusters which were in the process of losing their ability to contract spontaneously needed a progressively increasing temperature to induce spontaneous activity. These results suggest (1) that the pacemaker mechanism fails first when a cell cluster loses its spontaneous activity and (2) that shortly before the cluster fails to contract spontaneously, it requires more energy to maintain pacemaker activity because of possible structural membrane changes or changes in the enzyme pattern of the cells.


2020 ◽  
Author(s):  
Ada Admin ◽  
Nadejda Bozadjieva Kramer ◽  
Camila Lubaczeuski ◽  
Manuel Blandino-Rosano ◽  
Grant Barker ◽  
...  

Elevation of glucagon levels and increase in a-cell mass are associated with states of hyperglycemia in diabetes. Our previous studies have highlighted the role of nutrient signaling via mTOR Complex 1 (mTORC1) regulation that controls glucagon secretion and a-cell mass. The current studies investigated the effects of activation of nutrient signaling by conditional deletion of the mTORC1 inhibitor, TSC2, in a-cells (aTSC2<sup>KO</sup>). We showed that activation of mTORC1 signaling is sufficient to induce chronic hyperglucagonemia as a result of a-cell proliferation, cell size and mass expansion. Hyperglucagonemia in aTSC2<sup>KO</sup> was associated with an increase in glucagon content and enhanced glucagon secretion. This model allowed us to identify the effects of chronic hyperglucagonemia on glucose homeostasis by inducing insulin secretion and resistance to glucagon in the liver. Liver glucagon resistance in aTSC2<sup>KO</sup> mice were characterized by reduced expression of the glucagon receptor (GCGR), phosphoenolpyruvate carboxykinase (PEPCK) and genes involved in amino acid metabolism and urea production. Glucagon resistance in aTSC2<sup>KO</sup> mice was associated with improved glucose levels in Streptozotocin (STZ)-induced β-cell destruction and HFD-induced glucose intolerance. These studies demonstrate that chronic hyperglucagonemia can improve glucose homeostasis by inducing glucagon resistance in the liver.


2020 ◽  
Author(s):  
Nadejda Bozadjieva Kramer ◽  
Camila Lubaczeuski ◽  
Manuel Blandino-Rosano ◽  
Grant Barker ◽  
George K. Gittes ◽  
...  

Elevation of glucagon levels and increase in a-cell mass are associated with states of hyperglycemia in diabetes. Our previous studies have highlighted the role of nutrient signaling via mTOR Complex 1 (mTORC1) regulation that controls glucagon secretion and a-cell mass. The current studies investigated the effects of activation of nutrient signaling by conditional deletion of the mTORC1 inhibitor, TSC2, in a-cells (aTSC2<sup>KO</sup>). We showed that activation of mTORC1 signaling is sufficient to induce chronic hyperglucagonemia as a result of a-cell proliferation, cell size and mass expansion. Hyperglucagonemia in aTSC2<sup>KO</sup> was associated with an increase in glucagon content and enhanced glucagon secretion. This model allowed us to identify the effects of chronic hyperglucagonemia on glucose homeostasis by inducing insulin secretion and resistance to glucagon in the liver. Liver glucagon resistance in aTSC2<sup>KO</sup> mice were characterized by reduced expression of the glucagon receptor (GCGR), phosphoenolpyruvate carboxykinase (PEPCK) and genes involved in amino acid metabolism and urea production. Glucagon resistance in aTSC2<sup>KO</sup> mice was associated with improved glucose levels in Streptozotocin (STZ)-induced β-cell destruction and HFD-induced glucose intolerance. These studies demonstrate that chronic hyperglucagonemia can improve glucose homeostasis by inducing glucagon resistance in the liver.


2020 ◽  
Author(s):  
Nadejda Bozadjieva Kramer ◽  
Camila Lubaczeuski ◽  
Manuel Blandino-Rosano ◽  
Grant Barker ◽  
George K. Gittes ◽  
...  

Elevation of glucagon levels and increase in a-cell mass are associated with states of hyperglycemia in diabetes. Our previous studies have highlighted the role of nutrient signaling via mTOR Complex 1 (mTORC1) regulation that controls glucagon secretion and a-cell mass. The current studies investigated the effects of activation of nutrient signaling by conditional deletion of the mTORC1 inhibitor, TSC2, in a-cells (aTSC2<sup>KO</sup>). We showed that activation of mTORC1 signaling is sufficient to induce chronic hyperglucagonemia as a result of a-cell proliferation, cell size and mass expansion. Hyperglucagonemia in aTSC2<sup>KO</sup> was associated with an increase in glucagon content and enhanced glucagon secretion. This model allowed us to identify the effects of chronic hyperglucagonemia on glucose homeostasis by inducing insulin secretion and resistance to glucagon in the liver. Liver glucagon resistance in aTSC2<sup>KO</sup> mice were characterized by reduced expression of the glucagon receptor (GCGR), phosphoenolpyruvate carboxykinase (PEPCK) and genes involved in amino acid metabolism and urea production. Glucagon resistance in aTSC2<sup>KO</sup> mice was associated with improved glucose levels in Streptozotocin (STZ)-induced β-cell destruction and HFD-induced glucose intolerance. These studies demonstrate that chronic hyperglucagonemia can improve glucose homeostasis by inducing glucagon resistance in the liver.


1997 ◽  
Vol 110 (3) ◽  
pp. 217-228 ◽  
Author(s):  
Jesper Gromada ◽  
Krister Bokvist ◽  
Wei-Guang Ding ◽  
Sebastian Barg ◽  
Karsten Buschard ◽  
...  

We have monitored electrical activity, voltage-gated Ca2+ currents, and exocytosis in single rat glucagon-secreting pancreatic A-cells. The A-cells were electrically excitable and generated spontaneous Na+- and Ca2+-dependent action potentials. Under basal conditions, exocytosis was tightly linked to Ca2+ influx through ω-conotoxin-GVIA–sensitive (N-type) Ca2+ channels. Stimulation of the A-cells with adrenaline (via β-adrenergic receptors) or forskolin produced a greater than fourfold PKA-dependent potentiation of depolarization-evoked exocytosis. This enhancement of exocytosis was due to a 50% enhancement of Ca2+ influx through L-type Ca2+ channels, an effect that accounted for &lt;30% of the total stimulatory action. The remaining 70% of the stimulation was attributable to an acceleration of granule mobilization resulting in a fivefold increase in the number of readily releasable granules near the L-type Ca2+ channels.


1982 ◽  
Vol 95 (2) ◽  
pp. 215-227 ◽  
Author(s):  
P. R. Flatt ◽  
C. J. Bailey ◽  
K. D. Buchanan

This study examines the role of glucagon in the pathogenesis of the obese hyperglycaemic (ob/ob) syndrome in mice. Plasma C-terminal immunoreactive glucagon concentrations were measured in fed and fasted ob/ob mice at different ages between 5–40 weeks, and in 20-week-old mice after the administration of established stimulators and inhibitors of glucagon secretion. Plasma glucagon concentrations were inappropriately raised irrespective of age, nutritional status and the accompanying prominent changes in plasma glucose and insulin concentrations. Glucose suppressed plasma glucagon in the fed but not the fasted state, suggesting a dependence on the marked hyperinsulinaemia associated with feeding. Administration of 0·25 units insulin/kg to fasted mice failed to affect plasma glucagon and glucose concentrations. Increasing the dose to 100 units/kg restored the normal suppressive actions of insulin. Fasted mice showed an exaggerated glucagon response to arginine but not to the parasympathomimetic agent pilocarpine. Fed mice displayed normal plasma glucagon responses to the sympathomimetic agents noradrenaline and adrenaline. Administration of insulin antiserum or 2-deoxy-l-glucose raised plasma glucagon concentrations of fed mice. Contrary to the lack of suppression by glucose in the fasted state, heparin-induced increase in free fatty acids reduced plasma glucagon concentrations. This study demonstrates inappropriate hyperglucagonaemia and defective A-cell function in ob/ob mice. The extent of the abnormality is exacerbated by fasting and appears to result from insensitivity of the A-cell to the normal suppressive action of insulin.


Sign in / Sign up

Export Citation Format

Share Document